Cardiff Oncology (CRDF) PT Lowered to $21 at Piper Sandler
Tweet
Share
E-mailGet Alerts CRDF Hot Sheet
Price: $0.96 -2.04%
Rating Summary:
7 Buy, 5 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
7 Buy, 5 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Piper Sandler analyst Joseph Catanzaro lowered the price target on Cardiff Oncology (NASDAQ: CRDF) to $21.00 (from $25.00) while maintaining a Overweight rating.
You May Also Be Interested In
- William Blair Downgrades Cardiff Oncology (CRDF) to Market Perform
- Petronet LNG Ltd. (PLNG:IN) PT Raised to INR310 at ICICI Securities
- Fiserv (FISV) PT Lowered to $60 at Freedom Broker
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
